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cardiological interventions and often undermines the benefit of the intervention.
The incidence of postoperative neurological impairment varies depending on the






resonance imaging (DW MRI) scanning is a sensitive imaging method for the
detectionofcerebralinfarctionsthatareclinicallysilent.In31percentoftheCABG
patients and in seven to 15 percent of the patients who underwent a cardiologic
treatment for atrial fibrillation, DW MRI demonstrated new ischemic lesions
postprocedurally9,10.
 Impaired neurological function after cardiac procedures is associated with
substantialincreasesinmortality,lengthofhospitalisation,anduseofintermediate
or longterm care facilities. These put a considerable burden on the health care




procedures can be expected in the nearby future. These procedures are likely to





were of embolic origin 3, 8, 11. Most strokes presented already on the first
postoperative day (40%), implicating that they are presumably related to
intraoperative embolism. These early strokes are associated with a higher in
hospital mortality compared to delayed stokes 3, 11. The reduction of early stroke
might be accomplished by identification of embolic sources and according to that
redesignofclinicalprotocolsorequipmenttodiminishtheamountofemboli.




emboli passing through the cerebral vasculature, usually in the middle cerebral
artery(MCA).In1982Aaslidandcolleaguesdemonstratedthepossibleclinicaluse
ofTCD 12.Anultrasoundtransducerplacedoverthetemporalboneemitsasound
wave (typically with a frequency of 2 MHz), which is scattered back by the
intracranial structures and received by the same transducer. If the ultrasound is
scatteredbackbymovingblood,thereceivedfrequencywillaccordingtothewell
known Doppler effect differ from the emitted frequency, whereby the frequency
change directly correlates with the speed of the blood. It is hence possible to






to the backscatter of blood alone. Consequently, a shortlasting relative intensity
increase in Doppler power is encountered, giving rise to a typical sound, which is
easilyrecognisabletothehumanear.Additionally,thesignalintensityincreasecan
be made visible in the frequency domain (i.e. the Doppler spectrogram) or in the
timedomainandisusuallymeasuredindecibels.Thebackscatteredsignalscanbe






effective sample volume length 17. In practice, however, a correct size
determinationis impededbyseveralfactors,forexamplethecomplexrelationship
betweenthesamplevolumepropertiesandtheemboluspassingby.
 Applying advanced Doppler ultrasound instrumentation, Russel and Brucher
proposedanewmethodforthediscriminationbetweenthetwotypesofembolion




 The individual emboli measured during cardiac procedures do not cause an
obstructionofoneofthemaincerebralarteries,resultinginasubstantialreduction
flowfurtherdistally,whichmightleadtoacutecerebralsymptomatology.Therefore
these emboli are called microemboli (ME) that can be recognised by TCD as
microembolicsignals(MES).So,anindividualMEiscommonlyregardedtocauseno




However, if the number and size of all ME within a given time (the socalled
“embolicload”)exceedacertainthreshold,theasymptomaticnatureofMEappears
to be relative. This threshold currently is unknown and likely to be different for
gaseousandparticulateME20.
 ThedetectionofMESinthecontextofcardiacproceduresreliesinfirstinstance
on aural evaluation of the Doppler signal by a trained observer. Additional
information on the presence of an MES can be derived visually either from
spectrogramorthetimedomainsignal.Thismethodcurrently isconsideredtobe
the gold standard for counting MES emboli but it is very timeconsuming and
strenuousfortheexaminer.Intherecentyears,therefore,automaticMESdetection
systems havebeen developed. Although the reliability of counting relatively small
MESstemmingfromcarotidarteryplaqueshas improvedconsiderably,nocurrent




likely to have greater clinical significance than gaseous ME since they will block
distal arteries for a relatively longer period and hence cause cerebral ischemia.
Nevertheless, both particulate and gaseous ME may cause cerebral inflammation,
cerebral oedema and small capillary arteriolar dilatations, which in turn may be
responsibleforcerebralseizuresandcerebralmicroinfarctions9,2125.
 With theuseofTCDmonitoringduringcardiac surgery, several intraoperative
eventshavebeenidentifiedthatcontributetothetotalcerebralembolicload8,2628.
The specific manipulations or interventions which generate emboli are well
described However, the total number of detected cerebral emboli during cardiac
surgery procedures varies considerably between patients. Figures between 60
emboli29and2069embolihavebeenreported8.
 NumerousstudiesdemonstratedacorrelationbetweenthenumberofMESand
postoperative neurological complications 5, 8, 24, 26, 27, 30, 31. More specifically, a
correlationbetweenthenumberofcerebralMESandtheincidenceofthedegreeof
cognitivedeclinehasbeendemonstrated.DecreasingthenumberofcerebralMES






less than 1% 5, 31. So, the number of MES during cardiac surgery appears to be











As has been discussed, TCD monitoring whilst cardiac procedures allows for an
estimationoftheriskofneurologicalcomplications.Inordertoreducethatrisk,itis
important to identify the specific moments and sources of ME. On the one hand,
different stages of e.g. the CABG procedure are wellknown for their emboligenic
potential.On the otherhand, ME might occurunexpectedly, e.g. due to technical
failure.Apracticalexampleistheincorrectplacementofthevenouscannulainthe
rightatrium,resultinginsuctionofair intothevenouslineoftheCPB.Thisfailure
would remain unnoticed without TCD monitoring. However, immediate
identification of embolisation by intraoperative TCD monitoring can alert the
surgeon, and restoration of airless pump inflow can be accomplished, which will
resultinalimitednumberofcerebralMES32.
 An example for interventions causing ME that can reasonably be expected
duringCABGareperfusioninterventions,whichareknowntobeasourceofbubble
introduction in the arterial line 28, 32. These perfusion interventions are inevitable
during cardiopulmonary support, but possibly, adjustments of the equipment or
thestandardprotocolcouldreducethenumberofcerebralMEperioperatively. In
chapteroneofthisthesistwomethodsofaspecificperfusionintervention,whichis





risk 33. So, the mortality, disability, and costs related to cardioembolic stroke are
likely to be considerably reduced by advances in treatment of AF. However, PVI
itselfbears the riskof thromboembolic complications, i.e.also stroke. Ithasbeen
shown that clinically symptomatic neurological complications (TIA) occur in up to
2.2%34.Additionally,asymptomaticcerebralischemiclesionsarefoundondiffusion
weighted MRI images in 7% 9 of PVI patients. It was demonstrated that ME are
generatedduringPVIproceduresandthatthereisacorrelationbetweentheseME
andneurologicalcomplications 5, 31.UnderstandinghowemboliemergeduringPVI
and determining the number of ME are crucial steps to recognise possibly
adjustablesourcesofembolisationandthusbeingabletofindasolutiontoreduce
theamountofME.
 In chapter two we compare the occurrence of cerebral MES during a newly
developed epicardial PVI procedure, which is minimally invasive and uses a
thoracoscopic epicardial approach, with a standard endocardial method using a
radiofrequency (RF) ablation catheter for PVI. It is conceivable that the epicardial
I N TRODUCT ION 
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approach might differ from the endocardial approach with respect to its
emboligenicity since no intravascular manipulation is involved. We, therefore,
determined the specific moments and mechanisms of embolisation in both the
endocardial and epicardial PVI procedure, as well as the amount of cerebral MES
which is interpreted as a surrogate marker of the risk for neurological
complications.
 SinceithasbeenshownthatendocardialPVIisaccompaniedbytheoccurrence
of a large amount of ME, alternative catheter designs and techniques have been
developed.ApossiblecandidateforthegenerationofMEduringendocardialPVIis
local heating which occurs with most catheters used in clinical practice. Hence, a
conventional PVI catheter has been developed allowing for a relatively lower
workingtemperatureduetocoolingofthetipofthecatheter.Asecondalternative
applies a cryo energy source, using temperatures of 80°C. Hence local heating is
completely absent, which might lower the thrombogenicity of the PVI catheter.
Consequently, the risk of postprocedural neurological complications might be
favourableascomparedtotheuseofconventionalcatheterdesign.Inchapterthree
the rate of embolisation caused by three different catheter designs including the
twolattertypesisexamined.
 InthefirstthreechapterstheoccurrenceofcerebralMESisstudiedincardiac
interventions toprovide informationaboutembolisation in theseprocedures.The
total number of cerebral MES is used as an indication of the risk of neurological




Even if the number of ES can be lowered during cardiac procedures, it is unlikely
thatacompleteeliminationwillbefeasible.Forexample,duringCABG,cannulation
oftheaortaaswellasusingCPBwillirrevocablybeaccompaniedbyES.
 Commercially available devices to reduce cerebral ME during cardiac surgery
include arterial line filters, bubble traps in cardiopulmonary bypass systems and
intraaortic filters. The use of arterial filters or bubble traps during openheart
surgery can reduce the gaseous cerebral ME significantly during perfusion
interventions 35, but are not capable of lowering the cerebral microembolisation
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of the ultrasound field. Hence, the number of cerebral ME during cardiac surgery
mightbereduced.
 In chapter 4, we evaluated the safety of this new technology in an animal
experiment. Histopathological, haematological and temperature changes were
analysed inordertoestimatetheriskofsideeffectscausedby implementationof
the EmBlocker™. Additionally, to evaluate the efficiency in terms of lowering the
number of cerebral ME, known quantities of ME were injected into the animal
systemic circulation with alternating activation of the EmBlocker™. Assuming that
applicationof theEmBlocker™will indeed reducecerebralembolism inananimal
experiment,ithastobeshownthattheseresultscanbetranslatedintothehuman
situation. In chapter 5, we describe a clinical pilot study, were the number of
cerebral MES was compared between patients in whom the EmBlocker™ was
appliedandacontrolgroup.
Determinationofthecorrectembolicload
Severalattemptshavebeendescribed, including thosepresented in this thesis, to
reduce the amount of intraoperatively occurring ME and hence the risk of
neurological complications. Assuming that ME and neurological complications are
relatedtoeachotherthemostaccuratedeterminationofthecerebralembolicload
isrequiredifonewantstoestimatetheneurologicalriskfactorforagivencardiac







the Doppler spectrogram or the time domain signal. A remarkably high
interobserveragreementwasfoundforthisapproach39,equivalentorhigherlevels
ofagreementcouldbereachedinMESreadingthaninCTorMRIreading.
 So, counting the number the MES appears to be much more feasible than
evaluating size and composition of the embolus. We determined the number of
MESaccordingtotheabovementionedmethodinthefirstfivechapters.Forsingle
emboli this manual counting in practice is accurate and easily to accomplish.
However, during cardiac surgery it is quite common that a large amount of MES
passtheMCAinaveryshorttime,givingrisetoasocalledclusteror“shower”.In
thiscase,MESmightevenoverlap, i.e.stemfromdifferentdepthssimultaneously.
When such a cluster enters the Doppler sample volume, it is hardly possible to
determinetheexactnumberofME,neithervisuallynoracoustically,ifonerelieson
the Doppler signal. This drawback is likely to cause an underestimation of the
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numberofcerebralMEwhichenterthebrainduringsuchashowerandtherebythe
cerebral embolic load during cardiac interventions. So, until now a correct
estimationoftheembolicloadduringcardiacsurgeryisnotonlyhamperedbythe
inability to correctly identify the size and composition of the emboli, but also to
accuratelycountthenumberofemboliwhentheyoccurasacluster.
 An alternative method for evaluating MES does not rely on its velocity
characteristics, i.e. the Doppler frequency shift but on its amplitude properties.
Moehring et al. could show that the spatial resolution was considerably better,
using a multigated system. This socalled power Mmode technology is able to
simultaneously provide the Doppler shift, as well as the amplitude of the
backscattered ultrasound waves over a wide range of depths 40. Mess et al
demonstrated that emboli can be visualised with an even higher spatial and
temporalresolutionbyusinganofflinedigitalpostprocessingsystembasedonthe
analysisoftheunprocessedbackscatteredradiofrequency(RF)ultrasound41.So,the
latter technology might potentially improve the accuracy of emboli detection,
especiallyduringshowers.Inchapter6wepresenttheresultsofastudywherewe
used the RFbased emboli detection technology in combination with a novel
automaticdetectionalgorithmduringcardiacsurgery.

Finally, thegeneraldiscussionwillnotonlycoverthemostessential resultsof the
aforementionedchaptersbutalsoelaborateontheusefulnessofMESdetectionin
the evaluation of cardiac interventions and their risk of inducing neurological
complications.
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Perioperative cerebral microemboli in cardiac surgery are associated with
postoperative neurological complications cardiopulmonary bypass (CPB) and
perfusionistinterventionsareimportantcontributorsofmicroemboli.Inthisstudy,




either an open or closed CPB system. Patients were monitored with transcranial
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Introduction
Despite impressive improvements intheoverallsafetyofcardiacsurgery,cerebral
injury remains a major concern after cardiac surgery 17. The two major causative
factors for neuropsychological dysfunction after cardiac surgery are global brain
hypoperfusion and cerebral emboli, generated by either surgical or perfusion
relatedinterventions2,6,8.Reducingcerebralembolitodiminishneurologicalinjury
emboli should be a major goal in the fields of cardiac anaesthesia, surgery and
perfusion 2, 46. Since 1990, Transcranial Doppler (TCD) is used to detect cerebral
microembolicsignals(MES)inthemiddlecerebralarteries.Studieshaveshownthat
total emboli counts on the TCD during CABG can vary from approximately 200
cerebralMES2,9to2000cerebralMESperprocedure10.AsCPBandpredominantly
perfusionist interventionshavebeenshowntobethemainsourceofthecerebral
MES, this study has special attention to emboli occurring during perfusion 1, 9.





Fourteen patients undergoing isolated CABG or redo CABG were continuously
monitoredforMESinbothmiddlecerebralarterieswithTCD.TheusedCPBsystem
wasrandomlychosen,insevencasesanopenCPBsystemwasusedandinsevena
closed CPB system. The exclusion criteria used were: off pump coronary artery




roller pump (Sorin S.p.A., Mirandola, Italy) was used in both groups. In both CPB
groups a capillary membrane oxygenator with integrated heat exchanger (Capiox
3CXSX18RX),a40micronarterialfilter(JostraLeucogard,JostraMaquet,Hirrlingen
Germany),andahardshellcardiotomyreservoir (CapioxHEHC282,TerumoCVS)
were used. For the closed systems a softshell venous reservoir (Jostra JVR 1900,
Maquet) was used. Both CPB circuits were Bioline coated (Jostra, Maquet). For
properdeairingofthearterialcannuladuringinsertion,theventcaps(EdwardsLife
Sciences)havebeenused.






The open CPB systems is similar in components as the closed CPB except for the
absenceofasoftshellvenousreservoir.Thevenouslinewasconnectedtothetop
ofthehardshellvenousreservoir,whichinthissystemalsoservesasacardiotomy
reservoir. A threeway stopcock manifold served as a port for both injection and
blood sampling. For the administration of phenylephrine, an infusion pump was
installed to reduce the risk of air injection. The arterial side of the manifold was








In the closed CPB system two methods of blood sampling were used, called
“traditional”and“Eline”.IntheCABGprocedureswithopenCPBsystemonlyone
sampling method was used and officiates as control. Three methods of blood
sampling were compared in this study: i) open, ii) closed traditional, iii) closed E
line.
 In the “traditional” way of sampling, the sample syringe (2.5 ml) was flushed
into thevenoussiteof themanifoldwhichempties into thevenousCPB line.This
results in multiple flushes of the syringe before the desirable blood has been
collected in the sample syringe. In the “Eline” method a shunt was created to
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deviate flushsamples fromthemanifold to thecardiotomyreservoir.Thisassures
thatallbloodvolumeinjectedduringthebloodsamplingprocedurewillbeemptied





1. A TCD (Doppler Box, DWL, Compumedics, Singen, Germany) with two 2 MHz
probes was used to monitor both middle cerebral arteries. The cerebral TCD
recordingwasstartedatthebeginningofsternotomyuntilclosureofthesternum.
Additionally,another2MHzTCDdevice(SpencerPMD100,SpencerTechnologies,
Seattle, WA, USA) was used to monitor microembolic signals in the arterial and
venousCPBlines(figure1).Specialprobeconnectorswereclampedonthelinesto










of surgical interventions occurred in the 2 minutes time frame, the perfusionist
interventionswereconsideredadropoutfordataanalysis.
 ComputersoftwarefromDWL(QL1.5.1)wasusedtoreviewthedatafromthe
middle cerebral arteries. The Spencer PMD 100 contained onboard software to
reviewtherecordingsofthearterialandvenousline.Thecompleteprocedurewas





Atotalof14patientswere included.Table1 lists thegroupcharacteristics.There
wasnosignificantdifferencebetweenthetwogroupsregardingage,height,body
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Male:Female 2:5 3:4 
Age 61(6) 71(10) 0.090
Height 168(7) 168(7) 0.898
BW(kg) 74(11) 76(8) 0.385
BSA(m2) 1.85(0.2) 1.88(0.1) 0.274
BMI 26(3) 27(3) 0.53
MeanflowduringCPB(ml) 4471(449) 4514(333) 0.593
Bypasstimeinminutes 79(23) 79(21) 0.899
Crossclamptimeinminutes 51(13) 40(15) 0.695
Perfusionistinterventions 9(6) 7(3) 0.113
CPB: Cardiopulmonary bypass system; SD: Standard deviation; BSA: body surface area; BI: body mass
index

The total number of micro embolic signals (MES) during each procedure was
counted.Table2showstheaverageembolicountsduringthewholeprocedureof
bothgroups.Nosignificantdifferencewasdemonstratedbetweenthetotalnumber
of cerebral MES in the closed CPB and open CPB groups. In both groups, most
cerebral MES were detected while the patient was on bypass. In the open CPB












Completeprocedure 416(505) 246(167) 0.104
Bypasstime 377(494) 177(159) 0.080
















InarterialCPBline 0.36(14) 496(361)* 0.33(43)#
OnTCD 0.2(0.56) 72(69)* 0.22(0.67)#
*=Significantdifferenceto“Open”,#=Significantdifferenceto“Traditional”

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Acomparisonofthedifferentsamplingmethodsislistedintable3.IntheopenCPB
system group, 42 blood samples were used for data analysis. In the closed CPB
system group, 60 blood samples were analysed; 31 of the traditional sampling
methodand29 intheElinesamplingmethod.Abloodsample inanopensystem
producedanaverageof0.4MESinthearterialCPBline,and0.2MESintheMCAs.
In a closed system using the Eline an average emboli count of 0.3 MES in the
arterial CPB line and 0.2 MES in the MCA’s were observed. Sampling in an open
systemandinaclosedsystemwiththe“Eline”methodbothgeneratedsignificant




manifested in a variation in total number of cerebral MES; ranking from 200
cerebral MES 2, 9 to 2000 cerebral MES 10, 15. Although factors such as peripheral
vasculardisease, the incidenceof crossclampplacementandmanipulationof the
ascending aorta are of importance in generating perioperative emboli and could
cause various numbers of cerebral MES, they are not examined in this study 2, 8.
Anotherfactorwhichcouldplayanessentialroleinthedocumenteddifferencesin
number of perioperative cerebral MES, could be the method in which perfusion
interventions are performed, as suggested by the invitro study of Myers et al 11.
Theirstudyshowedsignificantdifferencesbetweenthesamplingmethods.Thiscan
beconfirmedbyourclinical study,whichdemonstrated fewerMES in thearterial
CPB line and in the cerebral vessels when taking blood samples in an open CPB






CPB group. The Eline method of sampling generated significantly less MES as
comparedtothetraditionalsamplingmethodasdemonstratedintable3.Apossible
higher number of cerebral MES during bypass in the closed CPB group could be
measuredwhenonlythetraditionalmethodofsamplingwasused.Althoughinthis
study no difference in the total number of cerebral MES could be determined
between the open and closed CPB system, there is a significant difference in
filtering capability between the two CPB systems used. A certain amount of air




MES were detected. This was in contrast to the 596 arterial MES which were
observed when using the traditional sampling method in the closed system. This
differencesuggestsahigherfilteringcapabilityoftheopenCPBsystemthanthatof
the closed CPB system. The use of a softshell venous reservoir in the closed CPB
systemcouldbethereasonforareducedfilteringcapacityassuggestedbyTayloret
al.9.Airbubblesmaybeabletorisemoreefficientlytothetopofthereservoir in
hard shell reservoirs. The Eline in the closed CPB system proved a reasonable
resemblance to the micro embolieliminating capacity of the open CPB system
duringbloodsampling.
Clinicalrelevance







two sampling methods were used alternately in each patient. The two sampling







cerebral MES in closed CPB group. This could be an important aspect for future
studiesonthissubject.
 The reliability of the “golden standard” counting method decreases when the
number of MES rises above approximately 10 MES per second. Empirically, we
found it impossible to quantify high density embolic showers with an emboli
interspacingof less than50mswithaural evaluation.CommercialautomaticMES
detectionalgorithmsfailhereaswell,sincetheirtemporalresolutionislimitedbya
refractoryperiodintheorderof0.1seconds16.Anewlydevelopedalgorithmcould
not be implemented yet, due to a maximum recording period of 3 seconds 17. In
high density showers the number of MES per second is too large for an accurate
estimation,andtheamountofembolicanonlybeapproximated.
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Conclusion
In this study,we have demonstrated that different methods of perfusionist blood
samplingareresponsiblefordifferencesinthegenerationofcerebralmicroemboli.





closed systems is expected to reduce the amount of MES in the circulation and,
therefore,isrecommended.
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Isolation of the pulmonary veins (PVI) using ablation energy appears an effective
treatment for atrial fibrillation (AF) with a success rate of approximately 80%.
However, postprocedural neurological complications still occur in 0.5%10% of all
patientsundergoingPVI,presumablyduetoembolism.Therefore,we investigated
theoccurrenceofcerebralmicroembolicsignals(MES)asasurrogatemarkerforthe
risk of neurological impairment of two different PVI methods: (1) percutaneous




thoracoscopic epicardial RF ablation (EPI) and ten patients (1 persistent AF and 9
paroxysmal AF) underwent a percutaneous endocardial isolation (ENDO).
TranscranialDoppler(TCD)wasusedtodetectMESinthemiddlecerebralarteries.
Results
An average of 5 (± 6) MES were detected during epicardial PVI procedure versus
















PVI procedures are efficacious providing a ± 80% success rate in terms of AF
treatment with multiple procedures. One of the complications of PVI however, is
the occurrence of cerebroembolic events, which occurs in 0.5%10% of the
catheter endocardial PVI patients 2, 49. The occurrence of emboli in the cerebral
vessels is the main cause of these complications. Although a single intravascular
measured microembolic signal (MES) in itself is not accompanied by clinically
relevantsymptoms,severalpublicationssuggestacorrelationbetweenthenumber
of cerebralMESandneurological impairmentorevenstroke 4, 1012.Weexamined




uses a bipolar radiofrequency (RF) ablation device, which can reliably create









a focal isolation seemed sufficient a percutaneous endocardial PVI (ENDO group)
wasperformed.Ifmoreablationlineswerelikelytoberequired,aminimalinvasive
thoracoscopicepicardialPVI(EPIgroup)waschosen.Exclusioncriteriaconsistedof
thepresenceof thrombus in the leftatrialappendage (LAA)anda leftventricular
ejection fraction <30%. The present study did not influence the decision which
ablationtechniquewasusedinagivenpatient.








before thestartof theprocedure, followedbysubcutaneous fractionatedheparin
until the day of the procedure. Transoesophageal echocardiography (TEE) was
performed 2448 hours before the procedure to rule out the presence of
intracardiac thrombus and to identify the possible presence of a patent foramen
ovale(PFO).AllENDOPVIswereperformedunderlocalanaesthesia.Twodiagnostic
catheterswerepositionedviathefemoralveinsintothecoronarysinusandatthe
Hisbundle region respectively as a reference for the ENSITE system (St. Jude
medical,Minnetonka,MN,USA).OnesteerablemultiplexelectrophysiologicLASSO
(12mm15mm20mm)catheter(BiosenseWebster,Diamondbar,CA,USA)andaRF
ablation catheter (Safire 4mm bidirectional (St.jude medical, Minnetonka, MN,
USA) were positioned at the orifice of the different veins. Placement in the left
atriumwasperformedbymeansofatransseptalpuncture.IfaPFOwaspresentno









Oral anticoagulation was halted in all patients 3 days before ablation followed by
subcutaneous fractionated heparin until the procedure. All epicardial ablation
procedures were performed by means of a minimal invasive thoracoscopic
approach on a beating heart by the same cardiac surgeon (MLM) 13. The EPI
intervention was performed under complete anaesthesia using three rightsided
thoracoscopicports.Thisprocedurehasbeendescribedextensivelyelsewhere 8, 9.
In short, the procedure is conducted after achievement of general anaesthesia
administered with a doublelumen endotracheal tube. TEE is performed in the
operatingroomtoverifytheabsenceofaleftatrialthrombusbeforethestartofthe
procedure and adequacy of LAA excision at the end of the procedure. The right
pulmonaryveinsareaccessedfirstbyanarticulatedlighteddissector(AtriCure,Inc,
Cincinnati, OH, USA). Next, the bipolar clamp is introduced through the port
incision.ThisbipolarRFclamp(Isolator,AtriCureInc,Cincinnati,OH,USA)isusedto
ENDOCARD IA L  V ER SUS  E P I CARD IA L  PU LMONARY  V E IN  I SO LAT ION 
 33
achieve linear, transmural ablation lesions. Bipolar RF energy is applied to
electricallyisolatethepulmonaryveins;3overlappinglesionsarecreatedtoensure
isolation. When the conductance of the tissue decreases to less than 0.0025 S,
typically after 8 s, an audible signal is automatically generated to indicate
transmurality of the lesion. The technique is repeated on the left side with the
addition of division of the ligament of Marshall. As on the right side, the bipolar
clamp is positioned into place to ablate the left atrial cuff adjacent to the left





the cerebral circulation. TCD (PMD 100, Spencer Technologies, Seattle, USA) was
usedtomonitorbothmiddlecerebralarteries (MCAs) throughthe temporalbone
windows for MES using two 2 MHz probes, fixed with a headband (Marc 600,
Spencertechnologies,Seattle,USA).Theprobeswereinstalledafterthepatientwas
positioned for the PVI procedure. Patients were monitored continuously from 30
minutes before the procedure until termination of the procedure. TCD recordings
were stored for later offline analysis. In our study, the detection of cerebral MES








Table 1 represents pre and postoperative patient’s characteristics of both the
groups.InTable2theamountofdetectedcerebralMESofboththePVIgroupsare
shown. No cerebral vascular attacks (CVAs) were observed periand
postprocedurally. One patient was excluded from this study, because no TCD
monitoringwaspossible.


























average number of cerebral MES during manipulation was 4 (± 5) and during the
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Table2:NumberofmicroembolicsignalsintheEPIgroupandintheENDOgroup










   Mean SD   Mean SD 
Totalnumberofcerebral
MES















Both epicardial and percutaneous endocardial PVI procedures generate emboli.
However,thenumberofcerebralMESdetectedduringbothPVIproceduresdiffers
significantly (Table 2). The EPI procedure induces scarcely cerebral microembolic
signalscomparedtotheabundantMESduringtheENDOprocedure.
Causesofemboli




During the ENDO PVI approach air can enter the systemic circulation during
insertion, manipulation and flushing of introducers or catheters. In this study 332
(±193) cerebral MES were detected prior to the first energy application, which
represents8%ofalltheMESdetectedduringthewholeENDOprocedure,asshown
intable2.Whenapplyingablationenergyontheendocardialwalloftheostiaofthe
PV, thecardiacendothelium isdamagedwhichmay lead toplateletadhesionand
activation, resulting in clot formation 15. Another cause of emboli during the
applications could be linked to high temperatures. To accomplish PV isolation
interfacetemperaturescanriseupto100°C16,17.Thishightemperaturemaycause
denaturationofproteinsandformationofthrombiinthebloodandcanalsocause
electrolyticphenomenacreatinggaseousemboli intothesystemiccirculation 16, 17.
The generation of thrombi and gas bubbles during the ablation applications are
knowntobeassociatedwithendocardialablationprocedures.Thrombusformation
on the surface of catheters (i.e., char formation) is another possible source of
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catheter is positioned epicardially around the pulmonary veins. No intravascular





 During the energy applications the blood temperature during the EPI PVI
ablation is not likely to increase significantly, as no direct contact between the
ablationcatheterandthebloodoccurs.Althoughaccomplishmentoftransmurality
byepicardialablationcouldactivateacascadeofclottingmechanisms,thedamage
instigated to the endothelium will be less than that created by the ENDO PVI
approach 21 and will most likely be not sufficient to generate microemboli. No
thrombus has been observed on the endocardial surface of the ablation line in
animals.8.
Clinicalrelevance
The number of periprocedural cerebral emboli is correlated with neurological




the composition of the cerebral emboli should be considered when assigning
neurologicalrisk,assuggestedbyPadanilam22.Thepossiblecausesandtherebythe
possible nature of the emboli found in both ablation techniques are mentioned
earlier. Because there is no invasion in the blood vessels during the EPI PVI
approach,noaircanenterthesystemiccirculationandallembolidetected inthis
procedure will most likely be solid, due to manipulation or possible intravascular
overheating. The composition of the emboli detected during ENDO PVI could be
differentdependingonthevariousphasesoftheprocedure.Theperiodofflushing
thecatheterswillmostlikelyberesponsibleforintroductionofgaseousemboli.The
nature of emboli recorded during energy application (66% of the total number of
cerebralMES),andmanipulationbetweentheapplicationsintheENDOPVI(26%of
the total cerebral MES), are not completely understood. Both thrombus 15, 18 as
gaseous formation 16, 17 could occur in both phases. Lickfett et al 6 demonstrated
with diffusionweighted (DW)MRI that 10% of the patients treated by a
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percutaneous endocardial ablation method, had cerebral embolic lesions
postprocedurally.Kilicislanetal 4showedthat,byreducingcerebralemboliduring
percutaneousablationareductionofneurologicalcomplicationscouldbeachieved,
suggesting that even without the knowledge of their constitution, the detected
emboliduringpercutaneousablationareresponsibleforneurologicalcomplications.
 The correlation between the number of cerebral emboli during a cardiac
procedureandneurologicalcomplicationsiswelldocumented4,1012.Areductionof
the periprocedural number of cerebral emboli results in a reduction of
postproceduralneurologicalcomplications4,10,12.Marroucheetal10andKilicislanet
al 4 demonstrated a similar correlation between cerebral microemboli and
postproceduralneurologicalcomplicationsduringENDOPVIprocedures.Ourstudy
showedthatduring theEPIPVIprocedure thenumberofcerebralMESoriginated
can be abolished compared to the abundant number of cerebral MES detected
duringtheENDOPVIprocedure,indicatingthatpatientsundergoinganEPIPVIare
potentiallylesslikelytodevelopneurologicalcomplications.
 Furthermore, the two PVI approaches in this study are relatively different in




study. The success rates found in this study seem to resemble the success rates
found in literature. For the RF bilateral epicardial approach, the previous studies
haveshownasuccessrateof91% 7, 8,all the10patients treatedwiththeEPIPVI
approachinthisstudyhadsinusrhythmaftera5monthfollowup.Thesuccessrate
of the ENDO PVI method in paroxysmal AF patients in this study is 90%, which is







Results of this study should be interpreted with caution since the sample size is
small.Nevertheless,thedifferenceinnumberofcerebralMESbetweenbothgroups
isverylarge.
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With the current available TCD systems, the nature (gaseous or solid) and size of
cerebral emboli cannot be reliably determined. In theory, the relative intensity of
thereflectedsignalofgaseousascomparedtosolidembolidifferswheninsonated
by different emitting ultrasound frequencies 23. Yet, the existing dualfrequency
transducer can not accurately discriminate between solid and gaseous emboli 24.
Therefore, no discrimination of emboli was possible in this study. Similarly, no
indication of size of emboli can be given due to the fact that a small gaseous
emboluscouldreflectthesamelevelofultrasoundasbigsolidemboli.
 This study examined cerebral MES as a surrogate marker of the risk of
neurological complications. Clinical outcome was not investigated in this study.
Although correlation between the number of cerebral MES and neurological
complicationshasbeenreportedinpreviousstudies,futurestudiesshouldfocuson
the clinical impact of the demonstrated difference in cerebral MES in the two
examined PVI procedures. In this respect, pre and postprocedural cognitive





percutaneous endocardial PVI. Taking into account the other procedural aspects,
andthereportedsuccessrate inAF,theminimal invasivethoracoscopicepicardial
PVI approach might become a feasible alternative to endocardial catheter PVI
procedures.
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Isolation of the pulmonary veins (PVI) using high ablation energy is an effective
treatment for atrial fibrillation (AF) with a success rate of 5095%; however,
postoperative neurological complications still occur in 0.5%10%. In this study the
incidence of cerebral microembolic signals (MES) as a risk factor for neurological
complications is examined during three percutaneous endocardial ablation
procedure strategies: segmental PVI using a conventional radiofrequency (RF)
ablation catheter, segmental PVI using a an irrigated RF tip catheter and
circumferentialPVIwithacryoballooncatheter(CB).
Methods
Thirty patients underwent percutaneous endocardial pulmonary vein isolation.
Ostialisolationwasperformedin10patientswithaconventional4mmRFcatheter









different ablation procedures. The use of an irrigated RF and a cryoballoon
proceduressignificantly fewercerebralMESthantheuseofconventionalRF fora
PVI procedure. Suggesting a higher risk for neurologic complications using
conventionalRFenergyduringapercutaneousPVIprocedure.
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Introduction
Atrial fibrillation (AF) is a highly prevalent cardiac arrhythmia, with an age
dependent increase in incidence. It is an independent risk factor for death and
stroke 1. Antiarrhythmic drug treatment and pulmonary vein isolation (PVI) are
standard treatment options. PVI has become a mainstream treatment for AF
whereby ablation energy is applied to electrically isolate the pulmonary veins 2, 3.
Catheter PVI procedures are efficacious with success rates approximating 80%.
However,oneofthecomplicationsofPVIprocedurehowever istheoccurrenceof
cerebroemboliccomplicationsin0.5%10%ofthepatients2,4,5.Severalpublications
support an association between the number of cerebral MES and neurological
impairment and stroke 4, 69. Therefore in this study, the number of cerebral MES
wasconsideredasariskfactorofneurologicalcomplicationsandexaminedduring
three different catheterbased PVI approaches: (1) segmental isolation with a






AF undergoing a PVI were included in this study. We compared three separate
cohortsinthreedifferentcentres:AcademicHospitalMaastricht(theNetherlands),
Cliniques Universitaires de MontGodinne, Yvoir (Belgium) and Erasmus Medical
Centre,Rotterdam(theNetherlands).Threegroupsweredefinedaccordingtothe
ablation catheter used in each centre: (1) conventional RF catheter (CRF), (2)
irrigatedRFtipcatheter(IRF),(3)cryoballooncatheter(CB).
Procedures
The investigation was approved by the Human Research and Ethics Committee of
the Academic Hospital Maastricht (the Netherlands), Cliniques Universitaires de
MontGodinne, Yvoir (Belgium) and Erasmus Medical Centre, Rotterdam (the
Netherlands).
SegmentalPVI
These procedures were performed under local anaesthesia and with femoral vein
punctures.Twoechoguidedtransseptalpunctureswerepreformedandasteerable
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circular electrophysiologic catheter (Lasso®, Biosense Webster, Diamond bar, CA,
USA)waspositionedattheorificeofthetargetedveins.Ablationwasperformedat
the atriovenous junction at sites showing the earliest PV potentials. The
introducerswerecontinuouslyflushedtopreventtheformationofthrombionthe
catheter.Detailsaboutthesegmentalablationhavebeenpublishedearlier3.
 The ablation catheter used for the conventional RF ablation was a 4mm
bidirectional RF ablation catheter (Saphire®, St.jude medical, Minnetonka, MN,
USA).ThemaximumpowerlimitfortheRFablationwasseton25Wto30W,witha
maximumtemperaturelimitof55°Cto60°C.






puncture, guided by intracardiac echocardiography. The ablation was performed
with a 28mm doublelumen balloon catheter (Arctic front®, Cryocath, Montreal,




After ablation, a circular 20polar catheter was positioned at the ostium of every
vein to check for PV potentials. The procedural endpoint was the absence of
pulmonary vein potentials in all of the targeted veins. If isolation could not be




All patients of all three groups were on oral anticoagulation for a minimum of 1
month before the procedure. This was stopped 2 to 3 days before the ablation.
Transesophageal echocardiography was performed 2448 hours before the
proceduretoruleoutpresenceofintracardiacthrombi.Theactivatedclottingtime
(ACT) was kept above 350 seconds during the entire procedure in the CRF
procedures,between200secondsand250seconds in the IRFprocedures,andan
ACT of 350 seconds was maintained in the cryoballoon procedures. After the
procedure,oralanticoagulationwasresumedwithatargetinternationalnormalized
ratiobetween2and3.





2.0 MHz probes, fixed with a headband (Marc 600, Spencer technologies). The
probeswerebyanexperiencedphysicianinstalledafterthepatientwaspositioned
for both PVI procedures. Patients were monitored continuously starting from 30
minutes before the procedure until termination of the procedure. TCD recordings
werestoredforlaterofflineanalysis.InourstudythedetectionofcerebralMESwas
performedbyablindedtrainedphysicianaccordingtheguidelinesoftheconsensus
committee 12. The TCD analyses were divided into different periods. The period
from transseptal puncture until the first ablation was considered the placement
period(placementperiod).Theperiodduringwhichablationenergywasdelivered
wasclassifiedastheablationperiod.Duetothedelaybetweenemboligeneration
in the pulmonary veins and arrival of these emboli in the cerebral vessels, a 10s
period after the end of ablation was included in the ablation period in all of the
differentmethods(ablationperiod).Theperiodfromthefirstablation,untiltheend
of the procedure, minus the ablation periods was considerate the manipulation
period(manipulationperiod).
Dataanalysis







All data was analysed using the statistical software package SPSS® version 12.0
(SPSS Inc., Chicago, IL, USA). A MannWhitney U test was used to compare the 3
different types of embolic showers in the different ablation groups. A pvalue of
<0.05wasconsideredstatisticallysignificant.










 ConventionalRF IrrigatedRF Cryoballoon
N 10 10 10
Male 9 10 7
Age(SD) 50(11) 53(14) 58(11)
PAF/CAF 9/1 9/1 10/0
PFO 2 1 1




PAF: paroxysmal atrial fibrillation, CAF: consistent atrial fibrillation, PFO= patent foramen ovale, TIA:
transientischemicstroke.
PVIprocedures
Atotalof741energyapplicationsweredelivered in30patients: in theCRFgroup
318 applications, in the IRF group 314 applications, and in the CB group 109
applications.TheCRFand IRFprocedureshada significantly shorter totalablation
time than the CB procedures (P = 0.01) (Table 2). The total procedural time was
significantlylongerintheCRFgroup(274min)versusIRFandCBgroup(185minP=
0.032and178minP<0.0001).TheACT levels in the IRFgroupweresignificantly
lower(ACT=210)thanintheCRF(ACT=371,P=0.017)andtheCBgroups(ACT=
364,P=0.05).
Table2:Procedurecharacteristics intheConventionalRFgroup,the irrigatedRFgroupand inthecryo
balloongroup.
 CRF IRF  CB  
 Mean SD Mean SD CRFvs.IRF Mean SD CBvs.CRF CBvs.IRF
Ablationtime(min) 24 10 16 9 p=0.347 79 42 P<0.0001 P=0.01
Timeperablation(sec) 45 15 34 17 p=0.008 300 0 P<0.0001 P<0.0001
Proceduraltime(min) 274 92 185 49 p=0.032 178 57 P<0.0001 P=0.711
ACT(sec) 371 106 210 33 p=0.017 364 90 P=0.909 P=0.05
Impedance() 200 10 115 14 p=0.04    
Power(W) 24 6 24 2 p=0.906    
Temperature(°C) 49 5 36 2 p=0.01    










 CRF IRF IRFvs.CRFCB CBvs.CRF CBvs.IRF
 Mean SD Mean SD  Mean SD  
MEStotal 3908 2816 1404 981 p=0.019 935 463 p=0.001 p=0.186
MESplacementperiod 332 193 745 467 p=0.015 377 297 p=0.624 p=0.03
MESablationperiod 2566 2296 105 71 p=0.01 163 91 p=0.001 p=0.266
MESmanipulation
period
1010 733 554 601 p=0.143 395 186 p=0.027 p=0.874
MESper1minuteof
ablation
92 144 7 20 p<0.0001 3 5 p<0.0001 p=0.03

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MES during the placement period was significantly higher in the IRF group (745
cerebralMES)comparedtotheothertwogroups(CB=377cerebralMES,P=0.03;
and CRF = 332 cerebral MES, P = 0.015). During the ablation period, less cerebral
MES were generated in the IRF group (105 MES) and in the CB group (163 MES)





The number of MES during contrast injections and single point ablation in the CB
group were analysed separately. On average 13 ± 2 cerebral MES were observed
duringeachcontrastinjectionsintheCBprocedure,resultinginanaverageof132±





Type I showers occurred during the CRF procedure at an average ablation
applicationtimeof41seconds(±16),withanaveragetemperatureperablationof







This study demonstrates that cerebral MES are generated in patients undergoing









It has been proven that cerebral MES are an indicator of systemic and cerebral
embolization,andareassociatedwithasignificantriskofneurologicdamage4,69,15,
16. Lickfett et al 5 demonstrated with diffusionweighted magnetic resonance
imaging that 10% of patients undergoing PVI with a RF catheter had cerebral
emboliclesionspostprocedurally.KilicislanetalandMarroucheetal4haveshown
that patients with cerebroembolic events had significantly higher numbers of
cerebralMES,suggesting thatwithout theknowledgeof theconstitutionof those
emboli, the cerebral emboli during catheter RF ablation are responsible for
neurological complications. The method of detecting cerebral emboli cannot
provideinformationofthecompositionoftheobservedemboli,butthemomentof
occurrencecanprovidean indicationabout thenatureof theobservedemboli. In
cryoballoon ablation, a majority of MES are observed during the placement and
manipulation phase and at end of each ablation. Since placement of a 14 Fr
transseptalsheathandcontrastinjectionsduringplacementofthecryoballoonare
involved in the placement and manipulation phases, it seems a reasonable
hypothesis that the observed MES during these phases are mainly caused by
iatrogenicgasinjection.Attheendoftheablationphase,however,theballoonthat
occluded thePV ostium (trapping injected contrast inside the PV) isdeflated. The
cerebralMESdetectedatthatmomentcouldbethereleaseoficechipsformedat
the balloonPV interface or the release of thrombi formed in the trapped blood
column behind the occluding balloon. But it could also be the release of trapped
contrastincludingsomeinjectedairwhichcouldberesponsibleforMESformation.
Although the nature of the detected emboli in the CB procedures cannot be
determinedwithcertainty, it is clear fromthis study thata lowernumberofMES
aredetectedduringtheCBprocedurecomparedtothemethodsinvolvingRF.The
observedlownumberofMESduringcryoenergydeliverywiththecryoballoonand
the absence of MES during with cryothermal segmental ablations confirms the
previouslyprovenlowthrombogenityofcryoablation1720.
 Both RF groups show a higher number of observed MES compared to the CB
procedureduringtheablationphase.IthasbeenshownthatRFenergyisnotonly
highlythrombogenic1719,21,22,butalsocausesthegaseousembolitoemergedueto
tissue disruption and temperature rises 13, 14, 23. Since this study confirms the
significant correlation between increasing number of cerebral MES with higher
power, duration and temperatures of the RF ablation, it confirms that the emboli
are correlated with the energy delivery. In the CRF ablations the type III cerebral
embolic showers may be prevented by reducing the duration of each ablation. It
also shows that reducing the catheter tip temperatures by irrigated cooling is an
effective means for reduction of cerebral MES, probably through prevention of
thrombusformationaswassuggestedearlier22,24.ThisshowsthatwhenusingRF








The activated clotting times during the ablation was not entirely uniform in all
groups.TheCRFandIRFmaintainedloweranticoagulationlevelsthantheCBgroup
which may pose a serious bias in this study. However, in the IRF group, although
beingthe leastanticoagulated,asignificant lowerMESwereobservedthan inthe







 This study did not include a neurological examination of the patients. No
observations were made of postprocedural neurological complications. However
duetoreportswhichhavedemonstratedacorrelationbetweencerebralemboliand
braindamage46, 8, 9, 15, 16, 28,alowerincidenceofneurologicalcomplicationsinthe
cryoablationandtheirrigatedRFtreatedpatientscanbeexpected.
Conclusion
This study demonstrates that the generated cerebral MES during a PVI procedure
aresignificantlowerwiththeuseofaCBcatheterandanIRFcathetercomparedto
theuseofaCRFcatheter.Theriskofpostproceduralneurologicalcomplicationscan
therefore be expected to be higher with the use of a CRF catheter during a PVI
procedure.
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in postoperative neurological complications. A new ultrasonic transducer
(EmBlocker™) can be positioned on the ascending aorta and activation of the
EmBlocker™ is expected to divert emboli to the descending aorta, thereby
decreasingemboli in thecerebralarteries. In thispreliminaryanimal study, safety
andefficiencyofthistechnologywereexamined.
Methods
In 14 pigs (±70kg) a median sternotomy was performed and the EmBlocker™ was
positionedontheaortaascendensat the levelof thebifurcationof theaortaand
theinnominateartery.Inoneanimaltemperaturemeasurementswereperformed.
During these measurements the EmBlocker™ was activated four periods 120
secondsofhighpower (1.5W/cm2)and fourperiodsof600secondsof lowpower
(0.5W/cm2). In the safety study (n=6), the EmBlocker™ was activated twice the
expected clinical duration (eight periods of 120 seconds of high power and,
subsequentlyoneperiodof20minutesoflowpower).Tissuesamples(controland
sonicated) were collected after 1 week for histopathological evaluation (aorta,
trachea, esophagus, vagus nerves). In the efficiency study (n=7), extracorporeal
circulation was installed. Emboli (air and solid (1200, size 500m 750m)) were
introduced in the proximal ascending aorta and the EmBlocker™ was alternately
activatedwithhighpowerforsolidemboli injectionsandlowpowerforairemboli





waswithin limits; lessthan42°Cfor2minutes intheaortawalldirectlyunderthe




The new ultrasound technology can safely be applied and is capable of reducing
emboli in the cerebral arteries during extracorporeal circulation. Use of the
EmBlocker™incardiacsurgerybearsthepotentialtolowertheriskofpostoperative
neurologicalcomplications.Clinicalfeasibilitystudiesareinprogress.
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Introduction
Several interventions in cardiac surgery are associated with the occurrence of
intraoperative cerebral emboli 14. Transcranial Doppler (TCD) is a noninvasive
methodwhichpermitsintraoperativelyvisualizationofthesecerebralemboli.Using
TCD, different causes of cerebral emboli have already been identified such as:
cannulation,cardioplegianeedleincision,crossclampplacement,startandstopof
cardiopulmonary bypass (CPB) and declamping 2. The composition of the emboli
canbeeithergaseousorsolid(fatorcalcifiedplaque)andismostlyrelatedtothe





study a new ultrasonic device is examined that has the potential to reduce the
numberofcerebralemboli.Anultrasonictransducer(EmBlocker™)ispositionedon
the distal ascending aorta and by activating the ultrasonic power emboli are
expected todivert into to the aorta descendens and thereby reducing the emboli




Three different protocols were part of this study. In one animal the temperature
was measured at different locations during activation of the EmBlocker™. In 6
animalsasafetystudywasperformed.FollowingEmBlocker™activationtheanimals
were kept for 1 week. After this week tissues were collected for histopathology.
During followup blood samples were taken to examine the haematology. In the
thirdgroup(n=7)theefficiencyoftheEmBlocker™wasassessedusingTCD.
Allanimals receivedhumanecare incompliancewith the“Guide for thecareand
use of laboratory animals” of the National Institutes of Health. The study was
approvedbythelocalanimalethicscommittee.
TheEmBlocker™
The new ultrasonic device, the EmBlocker™ (Neurosonix, OrYehunda, Israel),
consistofaround2.2MHztransducerwithadiameterof36mmwhichisdeveloped
CHAPTER  5 

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for placement on the aorta ascendens at the level of the bifurcation of the aorta
and the innominate artery after thoracotomy as shown in figure 1 and 2. The




The mechanism of the EmBlocker™ is based on the principle that an object with
different acoustic impedance (density multiplied by sound speed) than its







difference in acoustic impedance is, the higher the acoustical force on the object
willbe.Duetothefactthatthereishardlyanacousticdifferencebetweenredand
whitebloodcellsanditssurroundings,theultrasonicradiationpowerwillnotaffect
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divert gaseous emboli and an intensity level of the EmBlocker™ of 1.5 W/cm2 is
chosentodivertsolidemboli.
Animalpreparation:temperature
One pig (70 kg) was subcutaneous administrated with Xylazine, Diasepam and
KetamineHCl30minpriortointubation.Anendotrachealintubationwasconducted




2). Temperature sensors were placed in the beam of the transducer in the
esophagus, trachea, under aorta and on aorta. Also temperature sensors were
positionedincontrolareasontheaortaandintheesophagusoutsidetheultrasonic





Six female domestic pigs approximately 70 Kg (about 4 months old) were
subcutaneous administrated with Xylazine, Diasepam and Ketamine HCl 30 min
prior to intubation. After the baseline blood sample was taken, endotracheal
intubation was conducted and was followed by mechanical ventilation.
Maintenance of general anaesthesia was performed with isoflurane during the







surgically closed in layers and blood samples were taken. Each animal recovered
from anaesthesia in the operating room, and then was transported to the step




was given at the conclusion of the procedure. Bytril 1ml /20kg intramuscular
injection once a day for 4 days) and analgesic agents (Morphine single dose was
given at the conclusion of the procedure and Depirone in the first 24 hours,
continuedwithDepironefor3days)inthepostoperativeperiod.Aftereachclinical
stagetheanimalswereobserveddailyforsignsofdistressthatwouldindicatethe
need for administration of analgesics. 72 hours post surgery a blood sample was
taken. At day 7 postoperatively all animals were sacrificed. Blood samples were
taken prior to euthanasia. Post euthanasia: A midresternotomy was performed.
Tissues were taken from sonicated and non sonicated areas of the aorta, the
innominateartery(orthejunctionoftheinnominatearteryandaortaasasonicated




 Blood samples were analysed for general chemistry, free haemoglobin and
haematologyvariables.Bloodsamplesweretakenfromtheanimalatfourdifferent
points of time: At baseline (prior to any surgical intervention), at the end of the
surgery,72hoursaftersurgeryandbeforesacrifice(after1week).
Animalpreparation:efficiency









been started anaesthesia was maintained with a propofol IV drip. Monitoring
includedECG,bloodpressure,oxygensaturationandcapnography.
 A cardioplegia needle was placed in the aortic root distal from the arterial
cannula, which was used for emboli injections. Polystyrene DVB particles (Duke
Scientific Corp) (500m750m) were dissolved in a 10 ml syringe filled with a
mixture(1:33)ofserumandringer’slactate.Airemboliwerecreatedbymixing1ml
ofairwith9mlofblood.Immediatelyafterthemixtureofairwithbloodthe10ml
was injected. Each kind of injection was performed 10 times; 5 times without
EmBlocker™ activation (control) and 5 times with activation of the EmBlocker™
(sonicated).Theappliedpowerof theEmBlocker™ transducer isduringairemboli
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injections 0.5W/cm2 and for solid emboli injections 1.5W/cm2. At the end of the
experiment,allanimalsweresacrificedthroughapentobarbitaloverdose(bolus80
mg/kgi.v.).
 Forcerebralmonitoring, twotranscranial transducers (EmbodopDWL,Singen,
Germany)wereeachplacedoneacheyeofthepig.Throughtheopeningoforbita
of the eye, the ultrasound could pass the skull and penetrate into the white and
graymatterofthebrainandreachthecerebralbloodvessels.Acerebralbloodflow






fact that all animals are different and that each animal provides a number of






clinical improvement, gained weight as planned and reached their target sacrifice
dateingoodhealthandwithoutanysignsofillnessoradverseevents.
Temperature
In table 1 the temperature values are shown from the esophagus, the trachea,
under the aorta, on the aorta, control aorta and control esophagus at two time
intervals during two different power settings of the EmBlocker™. The high power
application(1.5W/cm2)resultsinthehighesttemperature(41.9°C)undertheaorta
after2minutes.Atthelowpowerapplication(0.5W/cm2)thehighesttemperature
measured (38.1°C) was observed under the aorta after 10 minutes . All sonicated








  Sonicated Control
  Esophagus Trachea Underaorta Onaorta Aorta Esophagus
  Mean Mean Mean Mean Mean Mean
 Time(sec) SD SD SD SD SD SD
Highpower 0 35.3 35.6 35.2 27 33.2 34.6
  0.3 0.2 0.3 2.7 2.1 0.3
 60 36.7 38.3 40.7 33 33.5 34.8
  1 1 0.9 2.1 1.9 0.5
 120 37.5 39.1 41.9 33.3 33.6 35.1
  1.3 1.2 1.1 2.1 1.9 0.6
Lowpower 0 35.3 35.6 35.3 25.5 33.1 34.6
  0.2 0.3 0.3 0.2 0.9 0.3
 300 36.5 37.3 38.1 28 33.2 34.6
  1 0.9 0.7 0.5 0.9 0.8
 600 36.5 37.3 38.1 28 33.2 35.1
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Onlytheatypicalfindingsofthehistopathologyresultsareschematicgivenintable
2. In5animalsabnormalities in tissuefromtheaortaweredetermined. In fourof
theseanimalstheabnormalitieswereestablishedincontrolas insonicatedtissue.
In one animal just the sonicated aorta tissue demonstrated abnormalities. In two





phosphokinase (CPK) are shown in table 3 at 4 periods in time (baseline, post
closure, 72 hours after thoracotomy and before sacrifice). The white blood cells
within normal limits during the entire followup period, but show a significant








Table 3: White blood cells (WBC), free haemoglobin (free HB) and creatine phosphokinase (CPK) are
shownatfourtimepoints.
 Baseline Postclosure After72h sacrifice
 Mean(SD) Mean(SD) Mean(SD) Mean(SD)
WBC(10^3CMM) 19.7(5.1) 15.7(2.9)* 18.4(3.7) 16(2.3)
FreeHB(%) 6.9(5.4) 5.1(7.5) 8.5(8.5) 3.2(4.2)
CPK(IU/L) 4606(224.2) 3189(1769)* 5109(2510) 1228(589)*
*=significantlychangedcomparedtothelastmeasuredvaluebefore.
Efficiency
Inallanimalsboth leftandrightvelocity spectraof thecerebralarteriescouldbe
visualized with TCD. The recorded signals in each animal were acceptable for the





middle cerebral artery from 182 emboli to 90 emboli, resulting in a reduction of




of solid emboli with 42% from 67 emboli to 39 emboli in the left middle cerebral






  Off On
  Mean(SD) Mean(SD)
Air Left 155(69) 65(52)
 Right 182(96) 90(84)
Solid Left 67(34) 39(26)
 Right 82(38) 46(29)
Discussion
Temperature




couple of hours. In animals the most sensitive organs (testes andbrain) did show




under the aorta the temperature reached almost 42°C, the time period was less
than2minutes.Inclinicalusetheperiodofactivationispretendedtobehalfofthe
time period which were used in this temperature measurements, resulting in a
temperatureundertheaortaof less than41°C.Thetemperaturerise inthe lower
power application of the EmBlocker™ did not exceed the temperature value of
38.5°C. This implies that the 0.5W/cm2 energy level of the EmBlocker™ produces
lessheatthanthe1.5W/cm2energy level,andcanthereforebeusedfora longer
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Intraindividual comparison of sonicated versus nonsonicated tissue, revealed no
effect of sonication, except in two special cases. The inflammation in the aorta
found in four animals (animal 1, 2, 3 and 5) was found as well in control as in
sonicated tissue.As this inflammation isa typical reaction toa surgicalprocedure
there can be concluded that these effects are not due to sonication of the
EmBlocker™perse.Inoneanimal(animal6)mildlyvascularisedandmildlyfibrotic
tissueoftheadventitiaoftheexternallayeroftheaortawasdemonstratedinjust
the sonicated aorta. Probably these findings can be ascribed to the surgical
procedure as well, in particular because in more animals even stronger reactions
were found in control and in sonicated tissue. Tracheitis (which is a common
infection in pigs) was found in two animals. In one animal tracheitis was also




Coagulation necrosis, which is considered to be a marker of damage caused by
ultrasoundinducedhyperthermia,wasnotobservedinanyofthetissuesamples.
Haematology
Blood analyses showed no specific effect of sonication (table 3). The high plasma
CPK,whichwasalreadydemonstrated inthebaselinemeasurement, ismost likely
caused by transportation of the animals just prior to the surgical procedure. The
reduction of the CPK value to a normal value in 7 days after the transportation,




The efficiency results show significant reduction of cerebral emboli due to
EmBlocker™ activation. The ultrasonic wave of the EmBlocker™ exerts a more
pronounceddiversioneffectongaseousembolithanonthesolidemboli,whichcan
be explained by the difference in acoustic impedance (as mentioned before)
betweenthetwotypesofemboliandtheirsurroundings.
CHAPTER  5 
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However both gaseous and solid cerebral emboli were reduced by use of the
EmBlocker™,butdespitetheuseoflowerintensityoftheEmBlocker™forgaseous
emboli, the reduction of emboli in the middle cerebral arteries is 10 % higher for
gaseousembolithanforsolidemboli.Theproofofprinciplewasdemonstratedby
thesepreliminaryresults;howeverthefinalpositioning,thefinalshapeandsizeof
the transducer could improve the efficiency. The EmBlocker™ seems to be an
efficient device to reduce cerebral emboli during extracorporeal circulation and
therebycouldreducepostoperativeneurologicalcomplications4,5,12.
Clinicalapplication
Neurological complications after cardiac surgery are well recognized and can vary
from cognitive decline, with an occurrence of 5% to 43%, to stroke with an
occurrenceof2%to8%15.Acorrelationbetweencerebralemboliandneurological
complications has been described in the literature presuming that a reduction of
cerebral emboli could reduce these neurological complications. Specific
interventionsduringcoronarybypassgrafting(CABG)andopenheartsurgerywere
identifiedtogeneratemostofthecerebralemboli;cannulation,cardioplegianeedle





bifurcation of the aorta and the innominate artery (figure 2). One minute of
activationoftheEmBlocker™duringtheinterventionsmentionedbefore,shouldbe
sufficient to divert the generated emboli. Because all interventions (except de












bedue to thehighstandarddeviationof theweightof theanimals.Theanatomy
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difference, particularly in innominate and in right common carotid artery, could
causeadifferenceinabsoluteflowtothecerebralvessels.Noflowmeasurements
weredonetoconfirmthishypothesis.
 In this preliminary study a surrogate marker (number of emboli) was used to
examine the efficiency of the EmBlocker™, no brain MRI or brain pathology has




twice the clinically pretended period of activation was used of the EmBlocker™.
Efficiency measurements show a significant decrease in cerebral emboli during
emboli injections during extracorporeal circulation. Use of the EmBlocker™ in
cardiacsurgerybears thepotential to lower theriskofpostoperativeneurological
complications.
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Perioperative cerebral microemboli in cardiac surgery are associated with
postoperative neurological complications. The EmBlocker™ (Neurosonix Ltd,






11 consecutive patients and activated for 1 minute (1.5 W/cm2) during seven
selected aortic manipulations and for10 minutes (0.5W/cm2) intermittently after
crossclamp removal. Transcranial Dopplerbased quantification of micro embolic
signalswasperformedinallpatients.
Results




perioperative cerebral microembolic signals. This new technology holds the
potentialtolowertheriskofpostoperativeneurologicalcomplications.




which are suggested to be correlated with the postoperative neurological
complications, such as cognitive decline, transient ischemic attack and stroke 1, 2.




sternotomy. The emitted ultrasonic forces deflect emboli in the aortic arch away
from the innominate and left common carotid arteries downstream to the
descending aorta. In this pilot study, the effectiveness of the EmBlocker™ was










into the cerebral vasculature. Because the difference in acoustic impedance
between red and white blood cells and its surroundings is very small, the
EmBlocker™activationsareunlikelytoaffectthesecells.
 ThedisposabletransducerTheEmBlocker™(NeurosonixLtd)hasanovalshape
(maximum, 15.8mm x 25mm x 14mm) and has only transmitting capacity. No
additional incision was required for the placement of the EmBlocker™ , and all
surgical manoeuvres were not affected by the presence of the EmBlocker™ . A
biocompatibledomefilledwithsalineisplacedoverthetransducerforcoolingand
alsotopreventthepresenceofairbetweenthetransducerandthetissue(Fig1).





A temperature sensor monitors the temperature of the transducer, and this will










be applied when gaseous emboli are to be expected and result in an equivalent
diverting effect. Therefore two intensity levels of the 2.2MHz EmBlocker™ were
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determined; for theair removalphase,a levelof0.5W/cm2wasdetermined,and
fortheaorticinterventions,alevelof1.5W/cm2.Bothintensitylevelsstayedwithin
temperature safety ranges of all underlying tissues in animal experiments. For
efficacy purposes, 0.5W/cm2 and 1.5W/cm2 energy levels proved to be efficient







In both groups, transcranial Doppler (TCD) (Embodop DWL, Singen, Germany)
examinationwasperformedbybilateralinsonationofthemiddlecerebralarteries.
The moments of EmBlocker™ activation (or imitation activations in the control
group) were marked and analyzed offline. Two blinded physicians manually,
independently counted, according to the established consensus criteria 6. All
interventionsweredivided in200mssegments.Eachsegmentwascategorized for
thepresenceor absence ofa MES by each observer.Only whenanagreement of
bothobserverswasachieved,itwasconsideredanMES.








undergoing a valve procedure with or without coronary bypass grafting. The
exclusion criteria for this study were a carotid atheroma higher than grade II,
protruding ascending aortic atheroma (atheroma grade > III), previous cardiac
operation,uncontrolleddiabetes(i.e.,fastingglucose>250mg/dl),riskforsurgery,
euroscore > 8, left ventricular ejection fraction < 40% (35% for aortic stenosis),
historyofstroke,abnormalclottingactivationwithaprothrombintime>60%,and
partial thromboplastin time > 2 than the normal, emergency procedure, and life
threateningdiseaseotherthancardiac.




The TCD transducers were positioned on the head just after placement of the
centralvenouspressureline.IntheEmBlocker™group,theEmBlocker™wasplaced
on the ascending aorta just proximal of the origin of the innominate artery after
sternotomy(Fig2).EmBlocker™activationsanddeactivationsweremarkedonthe
TCD recording. No EmBlocker™ was placed in the control group, but the control
console of the EmBlocker™ was present to imitate EmBlocker™ activations. Each
manipulation resulted in 1 minute of TCD recording, except the removal of air
phase,whichwasa10minuteTCDrecording.
EmBlocker™procedure
In 11 patients the EmBlocker™ transducer was positioned as shown in Figure 2.
PlacementoftheEmBlocker™didnothaveanyimpactonthevalveprocedure,and
itwasperformedaccordingtothestandardprotocol.
The EmBlocker™ was activated for 60 seconds (intensityof 1.5W/cm2)during the
selected aortic manipulations. The start of activation of the EmBlocker™ and
applying a marker in the TCD recording was synchronized with the surgeon and
perfusionist.IntheairremovalphasetheEmBlocker™wasactivatedfor90seconds
and switched off for 30 seconds (intensity of 0.5W/cm2). This sequence was




were made between the number of detected cerebral MES during the selected









terminate all the activations within 2 seconds, which appeared postoperatively,
causedbyaleakingbiocompatibledomeplacedovertheEmBlocker™.






 Control(n=10) EmBlocker™(n=10) pvalue
 mean SD mean SD 
Age 68,7 5,4 61,2 7,8 0,0962
Gender M=7,F=3  M=8,F=2  0,739
AVR 4  4  
AVR+CABG 4  0  
MVR/MVP 1  4  
MVR+CABG 1  2  
Aorticnonprotrudingatheroma 10  8  
Aorticprotrudingatheroma 0  0  
Aorticatheromagradenotrecorded 0  2  
IMTmax<1.0mm(NormalCarotid
Arteries)
4  6  
1.0mm=<IMTmax>1.3mm(Thickening
carotidArteries)
5  3  
IMTmeasurementsnotperformed 1  1  
Creatinineconcentration(preoperative) 87 14 82 11 0,447
Creatinineconcentration(postoperative) 106 31 85 12 0,095
Creatinineconcentration(leavehospital) 84 12 81 12 0,604
TimeonCPB(minutes) 119 48 107 29 0,739
TimebetweenCrossClampoffandDe
cannulation(minutes)
27 6.5 28 7.9 0,863
Lengthofoperation(hours) 3.35 0.51 3.37 0.38 0,813
LengthofstayinICU(hours) 66.5 85.7 25.7 9.2 0,093
Lengthofstayinhospital(days) 10.5 5.5 7.0 1.8 0,165
Efficacy
In all selected manipulations, the number of cerebral MES was lower in the
EmBlocker™groupcomparedtothecontrolgroup.Asignificantreductionof63%of
cerebralMESduringtheselectedaorticmanipulationswasaccomplishedbyuseof
the EmBlocker™. Due to activation of the EmBlocker™ the overall number of
cerebral MES was significantly reduced by 53%. No significant differences were
foundbetween thenumberofMESdetected in the leftand rightmiddlecerebral
arteryinbothgroups.
Discussion
This study has demonstrated that theuseof theEmBlocker™ is associated with a
significant perioperatively reduction in cerebral MES. No difference in operation






The lowernumberof cerebralMESdemonstrated in theair removal phaseof the
EmBlocker™groupwasnotstatisticallysignificant,whichcouldbeduetothehigh
standarddeviationandtheembolicountingmethod.Thehighstandarddeviationin








EmBlocker™Control  EmBlocker™ Control






Cannulation 7 16 0.063  3 4 0.529 9 7 0.28
 10 14        
Cardioplegianeedle 2 3 0.095  1 1 0.971 2 1 1
 5 3        
CPBon 3 4 0.962  2 2 0.912 2 2 0.62
 4 8        
Crossclampon 4 15 0.796  2 2 0.796 12 3 0.796
 4 37        
Crossclampoff 20 21 0.631  12 8 0.529 10 11 0.631
 23 29        
CPBoff 10 36 0.065  5 5 0.971 20 16 0.931
 10 36        
EE 252 519 0.218  133 119 0.853 252 266 0.853
 145 458        
Decannulation 4 14 0.113  2 2 0.258 7 6 0.796
 4 15        
         
Total 303 622 0.043 * 160 143 0.684 312 310 0.912
 156 436        
distributionratio     1.00 1.00  1.12 1.00 
          
Aorticinterventions 51 103 0.019 * 27 24 0.684 60 44 0.684
(totalminusdeairing) 26 55        

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ThecerebralMEScountingmethodchoseninthisstudyisahighlyreproducibleand
reliable method, but the choice for segments of 200ms restricts the counted
number of MES in 1 second to 5 MES. A new developed algorithm could not be
implemented yet, due to a maximum recording period of 3 seconds 8.
UnderestimationofthecountedMESwilloccurwhenthedensityofemboliishigh




demonstrated in the right middle cerebral artery (54%) versus the left middle
cerebralartery(49%)bytheuseoftheEmBlocker™,whichcouldbeanindication







or descending aorta. Therefore, no quantification of the generated or diverted
embolicouldbemadeinthisstudy.
 Although the physicians are blinded for the TCD data, the surgeons were not




In this pilot, clinical study, the activation of the EmBlocker™ during selected
interventionsthatareproneforembolization(i.e.,cannulation,cardioplegianeedle




Therefore, these results suggest that the EmBlocker™ technology holds the
potentialtodiminishtheriskofthepostoperativeneurologicalcomplications.
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During cardiac surgery a large amount of cerebral microemboli can occur at once
and create so called “cerebral embolic showers”. To correlate postoperative
neurological outcome tocerebral embolic load, a quantitative evaluation of these
embolic showers is necessary. The standard monitoring technology to visualize
cerebralmicroemboliistranscranialDoppler(TCD).AlthoughtheconventionalTCD
systemsareequippedwithsoftwareclaimingtodetectmicroembolicsignals(MES),
none of the existing TCD systems is capable of an accurate estimation of the
numberofcerebralmicroemboliinembolicshowers.
Methods
In this study, an algorithm with a high temporal resolution, based on the radio
frequency(RF)signalofaTCDsystem,hasbeendesignedtoquantifytheseshowers.
Results





Doppler methods, considering that accurate estimation of the embolic load
supportsquantificationofneurologicalriskduringvarioussurgicalprocedures.





















by Cowe et al. 6, who also demonstrated that with an automated detection




algorithm for embolic showers. The predictability of embolic shapes in showers is
lessobviousthanfor isolatedemboli.Furthermoreduringembolicshowers,depth
resolution ismore important than informationaboutblood flow,whichcalls fora
shortlengthoftheemittedultrasoundburstsasdemonstratedbyMessetal.5.who
useda2μsburst,comparedtothelonger13μsburstusedbyCoweetal.7.
 In this study, an algorithm was designed for detection of emboli in showers,
basedonvelocity,durationanddepthrangeofMES.Theproposedalgorithmwas
tested on various recordings made during cardiac surgery to investigate its
applicabilityforclinicalpractice.






X 4, DWL, Sipplingen, Germany) was used to send 2 MHz ultrasound pulses at a
given pulse repetition frequency (PRF) and to acquire the echo and Doppler
(audio)signal from the middle cerebral artery (MCA). The RF echo signal, internal
clockandpulseemissiontriggerweremadeavailableandconnectedtoa12bitAD
converter of the acquisition computer. The signals were continuously fed to the
ADC,withasamplingfrequency(fs)of8or16MHzdependingontheDopplerunit
used,andstored intoatemporarybufferabletocontainapproximately3softhe













       (1)
 where T is the length in s of the acquisition, andd [m] is the width of the
acquisitionwindow.TypicallythePRFwas5kHzwithanacquisitionwindowwidth
of 30 mm, symmetrically around the depth setting of the TCD device. For TCD
systems,thedurationofemittedburstisvariedwiththesamplevolumesetting.It
was chosen as short possible with maintenance of reasonable signal intensity, to
achieveahighdepthresolution.Themeasurementswereexecutedwithasample





pctd         (2)
where dmin is the minimal distance along the ultrasound beam between two






        (3)
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Using a burst length of 2 μs a spatial resolution of approximately 1.5 mm can be




the University Hospital Maastricht, the Netherlands. All data were obtained from
patients undergoing cardiac valve operations. Emboli showers occurring after
releaseoftheaortacrossclampwererecorded.TheseshowerscontainmostlyMES
from gaseous emboli, although it might be possible that some solid emboli were
present as well. In total 11 patients were investigated, but two were eventually
excludedduetoaninsufficientacousticwindow.Oftheremaining9patients5were
randomly selected for a training set to optimize the parameters of the algorithm




thestandard in literaturewith thedepthdimension (fast time)along theyaxis (n
pixels)andtheslowtimedimensionalongthexaxis (mpixels).Noweachcolumn
(depth or fasttime dimension), is highpass filtered using a fourth order
Butterworth filter with a cutoff frequency of 500 kHz, to eliminate any DC
componentscausedby a misalignedcoupling to the ADC. Then the instantaneous
signal envelope S[n] is obtained using a Hilbert transformation of each column
(convolution with 1 / ( t)):
~
[ ] [ ] [ ]S n s n i s n  , where S[n] is the signal
amplitude,and
~
[ ]s n  is theHilbert transformof theoriginal signal.Brandsetal. 8
showedthattheerrorinamplitudeandphaseoftheHilberttransformisnegligible














In the depth direction the intensity distribution of a single reflector attains the
Gaussianshapeof thespatial sensitivity functionof theultrasoundsystem. In the
caseofanembolustravellingtowardstheprobe,thedepthofthereflectionofthe
embolus decreases over time. As a consequence also the Gaussian intensity
distributionshiftstowardslowerdepthsastimeincreases.Thisexplainsthetypical
‘comet’ like shape as observed in figure 1. Because of the high amplitude of the
reflection of a gaseous embolus compared to blood theMES appears to protrude
outside the vessel. Instantaneous MES intensities are given in dB, comparing the
peakamplitudeoftheMEStotheaverageamplitudeoveralldepthsofthematrixin
a region without visual MES. To ensure that the selected region did not contain
MES,usuallyareferencerecordingismadeatthebeginningofthesurgery.
 ThestandardwaytoclassifytheintensityofMESistheembolustobloodratio
(EBR) which can be extracted from the demodulated Doppler signal. For an RF
amplitudematrix,thedepthwithabloodsignalcanbefoundexploitingthesignalto
noise ratio (SNR) as provided by a simply to apply crosscorrelation model 8. It
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The algorithm designed in this study to detect and count emboli bears some
similarities to the algorithm proposed by Cowe and Evans 7. To create a
parallelogramaroundaMESinthe2dimensionalamplitudeplot(figure3),alllocal
maximaaboveacertainamplitudethresholdT1(e.g.15dB)withinacertaindepth
range (e.g. 4560 mm) are located. A second threshold is defined as T2, a certain

















Basedonourobservation, thevelocityofemboli in theMCAranges from5 to90
cm/s with a duration between 10 to 300 ms, while the depth range varied from
around3to20mm,startingfromthepresetdepth.Thesecharacteristicsareused
toestablishcriteria(slope,durationanddepthrange)forthecharacterisationofan
event. An event is considered to be a MES when all criteria (see table 1) are
satisfied.Theprocedureisrepeatedforallotherlocalmaximaintheamplitudeplot.










The processed RF matrices were read by 3 independent observers. The observers
were instructed to classify an event based on their own intuition and experience,
provided the event occurred within a predetermined depth range and was
completelywithin theRFplot.FinallyaneventwasclassifiedasMESwhen itwas
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whereaistheproportionofeventsallthreeobserversagreedtoclassifyasMES,cis
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In the training set, the proportion of specific agreement between the three
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EBRcalculations
For 45 randomly chosen MES in four patients the calculated EBR value is plotted
against the peak value in the RF amplitude plot (figure 5), exhibiting a linear







significant improvement compared to existing methods, which are not capable of
providing an appropriate indication of the number of cerebral microemboli
occurringduringembolicshowers.Duetothefactthatembolicshowersaremainly
composed of gaseous microemboli an accurate estimation of the number of
microemboliissufficienttoestablishclinicalrelevance.
ComparisontoDopplervelocityspectra




1.5and1.6 s shows twoMES,where the rightpartof the firstMESoccursat the
same time as the left part of the second but at a different depth. In the spectral
Dopplerplot (figure6a) theyappearasacontinuousstreakof increased intensity,
whileintheRFplot(figure6b)bothMESareclearlyseparated.
 To estimate the incidence of overlapping emboli, the percentage of overlap
timerelativetothetotaltimeemboliarepresentiscalculatedasdemonstratedin
figure6b.The test set consistedof21 recordingsof2.5s, yieldinga total timeof
52.5s.Emboliwerepresentduringapproximately6s.Thetotaltimethat2ormore
emboliwerepresentwithinthepredetermineddepthrangewas1.04swhichis17%
of the total time emboli were present. In total 151 of the 388 emboli are
overlapping,ofwhich33areevenforourmethodtoocloselyspacedtoresolve.






Figure 6: Doppler spectrum (A) and RF amplitude plot (B) of the same period in time. The Doppler
spectrumwascalculatedbasedontheRFsignalrecordedfromthe54to58mmdepthrange.Thetime
emboli are present and the time their signals are overlapping are indicated by black bars above the
illustration.

When all the overlapping emboli would be detected as a single embolus, the
sensitivityandPPVwoulddegrade from0.7and0.96 to0.4and0.9, respectively.
Thisdemonstratesthesignificantincreaseinsensitivitytheproposedmethodyields
inembolicshowers.





occur. This is corroborated by figure 5, showing an apparent linear correlation
betweenEBRandembolicpeakvalue.Duetotheuseofshortultrasoundburstsand
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twodimensionalRFamplitudeplotswhichretainsdepthandtimeinformation,the












drastically for EBRs below 10 dB. However, the detection threshold varies
significantly with the phase of the cardiac cycle at which the embolus occurs 11;
duringdiastoleevenadetectionthresholdof2dB is feasible.However, theblood
flow is still pump assisted when most showers occur, which makes a discussion
aboutthecardiacphaseirrelevant.
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In the present study, for a detection threshold of 10 dB peak value, the








It should be noted here that there is no unique definition of the EBR while the




Negative (FN). An increase in the number of FPs will yield a lower PPV, while an
increase in the number of FNs will give a lower sensitivity. A source of false
negatives is emboli with a temporal interspacing shorter than the temporal
resolution of the algorithm. The theoretically achievable resolution for a pulse
length of 2 μs is a spacing of 5 ms between the local maxima of two MES with a
typicalvelocityof30cm/s.Inpracticesomebroadeningoftheintensitydistribution
occurs (as shown in figure 9), and consequently the temporal resolution of the
algorithmisaround20ms.Thiscorrespondstoaspatialresolutionof6mm.Emboli
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before crossclamp release. One has to ensure in this case that no emboli are
presentintheintervaloftherecording.Possiblythedetectionthresholdcanalsobe
adapted to the patient, using postpriori knowledge about the signal strength.
Decreasingthethresholdtowardsthespeckleintensity,however,meanssacrificing
specificityandcalculationspeed.
 AnothersourceofFNs isaMESwithanarcedpathway. If the localmaximum
occurs in the downward part of the MES, it is often not classified as MES. These
MES,however,rarelyoccurredinourdatasets.
 The two most important sources of false positives are artefacts and double
counting of a single MES. Double counting can be prevented using a more
sophisticated method of placing a contour around an event. Considering that the
MESshapes may vary between patients, the variations should be identified to
implement an accurate contour method. Artefact rejection can be improved by
using a velocity plot, where the velocity for each pixel is calculated using the
complex crosscorrelation velocity estimator described by Brands and Hoeks 8. An
example of the advantage of the RF velocity plot is shown in figure 10. In the RF
amplitude plot (figure 10b) an obvious artefact is visible, which possibly can be
misclassified as a MES. In the velocity plot (figure 10a) the pixels forming the
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artefact do not exhibit a well defined velocity, whereas MES consistently have a
velocity higher than 0. Unfortunately plots, obtained using the crosscorrelation
process,havealowerresolutionthantheamplitudeplots.Asaconsequencewedid
not yet succeed to implement this method in the algorithm. Ideally, with future









QUANT I F I CAT ION O F  EMBOL I C  SHOWERS U S ING  R F  BAS ED  T CD  ANALY S I S 
 93
Conclusion
RF amplitude plots based on sample volumes with a short effective length of 1.1
mm visualise MES in embolic showers more evident than velocity spectra and
Doppler audio signals of conventional TCDsystems. Thealgorithmbased on short
pulsed RF amplitude plots provides quantitative information about large emboli
densities ("showers") during cardiac surgery, because of its excellent temporal
resolution.The results showthat thealgorithm isable toestimate thenumberof
emboli in embolic showers with a sensitivity of 0.71 and a PPV of 0.96. This is a
significant improvement compared to existing methods, which tend to fail for
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Cerebral injury is one of the most feared complications after cardiac procedures.
Embolisation isan important factor in this respect.Mostemboligeneratedduring
cardiac procedures are relatively small and are therefore called microemboli.
Nevertheless they can lead to neurological damage. Consequently measuring the
number of microemboli entering the cerebral vasculature can be used as a
surrogate marker for neurological impairment. In order to minimise the risk of
neurologicalcomplicationsduringcardiacprocedures,notonlythetotalamountof
microemboli generated during the whole procedure is relevant. If the number of
cerebral microemboli has to be reduced it is important to identify the specific
momentsofembolisation,inordertobeabletoadapttheactionstaken,ifpossible.
With Transcranial Doppler (TCD) it is possible to identify cerebral microemboli
perioperatively.
 This chapter will discuss the possible role of TCD monitoring during cardiac
procedures in minimising the risk of neurological complications. Special attention




Measuring cerebral microemboli during cardiac procedures allows for estimating







replacement) can readily be examined in terms of the generation of microemboli
encompassing unrecognised embolic sources. Consequently, a thorough
understandingoftheprocedural interventionsgeneratingembolicanbeobtained,
which in turn provides the opportunity to optimise the procedure in terms of
emboligenicity.
 Intraoperative TCD monitoring provides real time information regarding the
occurrence of cerebral microembolic signals (MES), allowing for immediate feed
backactioninordertoreducethenumberofcerebralmicroemboli.Thestudiesof
Marrouche, Kilikisclan and Murkin 13 illustrate this interaction during pulmonary
vein isolation(PVI). IncasecerebralMESoccurred,theenergydeliverywashalted
immediately, which in turn led to a reduced embolic load. Another example is
demonstrated by Lunch et al 4 in the context of coronary artery bypass grafting
(CABG). The appearance of cerebral MES indicated an incorrect position of the
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venous cannula. Readjustment resulted in instant cessation of cerebral
microemboli.
 So, a TCD guided reduction of cerebral microemboli is feasible. However, in
most cardiac procedures a complete elimination of cerebral microemboli is
impossible. A method preventing emboli from entering into the cerebral vessels
mightreducethecerebralembolicload.
 UltrasonicenergyisabletoreducethenumberofcerebralMESduringcardiac
surgery by diverting emboli emerging in the ascending aorta towards the
descending aorta. This has been demonstrated in chapter 4 and 5 of this thesis,
which also showed that this method could be applied safely. Yet, important
questions remain to be answered. Although the brain appears to be the most
sensitive organ for embolic load other organs have not been proven harmless.
Furthermore,theefficacyofthisultrasonictechnologyintermsofclinicalendpoints
still has to be shown. Since severe neurological complications occur in
approximately35%ofcardiacinterventions,aconsiderablylargerpatientgrouphas
tobestudiedthanwasdoneinchapter5.Settingupastudywithclinicalendpoints,
onehasalso to take intoaccount thata strokemightnotbe related toembolism
and that patients show a very large variation of the number of MES during the
procedure.Thesetwofactorsaddtotheneedforlargepatientgroupstobestudied.
An alternative, yet second choice, might be a study where pre and postoperative
cerebral imaging is applied, allowing for detecting also clinically silent cerebral
lesionsthatoccurredperioperatively57.
Pharmacologicaltreatmentforcerebralembolisation
So far, methods are described that aim at decreasing the amount of cerebral








 The formation of particulate emboli can be inhibited by antiplatelet and
anticoagulation drugs like asparin, warfarin and heparin 8, but the optimal
antiplatelet/anticoagulationstrategy isstillundefined 9.Fluorocarbonsarecarbon
fluorinecompoundscharacterisedbyahighgasdissolvingcapacityandadditionof
these compounds in the cardiopulmonary bypass prime solution leads to a
reduction in the incidence and severity of neurologic injury in animals 10. An
alternative might be hyperoxygen therapy, in which the patient breathes 100%






 Several treatment options have been discussed if cerebral embolism has
occurred.Withinafewhoursoftheonsetofstroke,administrationofthrombolytic
drugscanimproveclinicaloutcome1214.Newconceptsofapplicationofultrasound
with or without simultaneous administration of microbubbles to thrombolytic
therapyofferspromisingresultstoimproverecanalisationofintracerebralvesselsin
animals13.
 To increase the tolerance to ischemia barbiturates can also be given
postoperatively to reducecerebraloxygenconsumption, intracranialpressure, the
production of free radicals and the release of catecholamines to suppress the
consequences of gas bubbles 15, 16. There is also evidence that prophylactic
administration of heparin, decreases neurological impairment in animals after
cerebralairembolism17.
 Althoughtheclinicalvalueofthesetreatmentoptionsinthecontextofcardiac
interventions has to be proven, they offer new approaches to achieve a better




complications, yet, this relationship is complex, and there is no simple linear
correlation.IfMESareexpectedtobeasurrogatemarkerforbraindamage,several
aspectshavetobetakenintoaccount.
 First, the incidence of asymptomatic lesions after cardiac interventions as
measured with MRI is higher than clinically evident neurological complications.
Hence,intraoperativelyoccurringcerebralMEScancauseischemiclesionsthatare
notalwaysclinicallyrelevant.So,itisconceivablethattheamountofcerebralMES
shows a better correlation with postoperative MRI as compared to preoperative
MRIratherthanwithclinicallymanifestneurologicalimpairment.
 Second, the estimation of the embolic load is not optimal. Even though
countingthenumberofcerebralMESmakinguseoftheexistingmethodologycan
beconsideredasapotentialriskmarkerforneurologicalimpairment,itislikelythat
a more accurate estimation of the amount but also the composition of cerebral
emboliwillallowforabettercorrelationwithcerebraldamage.
 Counting cerebral MES during cardiac interventions is hampered by at least
factors. No commercially available automatic detection system is capable of
countingMESaccuratelyiftheintensityoftheMESvarieswidely,whichisthecase
in these circumstances. Instead, the gold standard of counting cerebral MES is
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definedbyhumanevaluation.Twotrainedobserversusetheaudioandvideosignal
to manually count the MES. When a consensus between the two observers is
achieved an intensity increase within the Doppler signal is considered to be
consistent with embolus. For a single embolus this counting method has been
provenreliable19.Yet, it isobviousthatareliablecountingofthenumberofMES
duringtheinterventionalprocedureishardlyfeasibleandquitetimeconsuming.
 Additionally, in cardiac interventions embolic showers often do occur, i.e.
emboli do not appear isolated but follow each other rapidly, so that they even
might occur at the same time in the sample volume. With the conventional
evaluation method as described above, it is not possible to discriminate between
theindividualMESanymore,whichwillinevitablyleadtoaninaccurateMEScount.
 So,areliableautomaticestimationofthenumberofMESisdesirableinorder
to improve the correlation with neurological outcome. Chapter 6 provides a new
methodtoquantifythenumberofcerebralMESeveniftheyoccursimultaneously,





to exert more damage than gaseous microemboli. This has been confirmed by
severalstudies.Sylivrisetal 20foundthatthenumberofcerebralMESasdetected
during aortic manipulation showed a significant correlation with postoperative
cerebral ischemic lesions by means of MRI. These MES are most likely to be of
particulatenature.Onthecontrary,thetotalnumberofMES,whichconsistsofnot
onlyofparticulatebutalsoofalargegroupofgaseousemboli,wasnotcorrelated
with cerebral ischemic lesions. Omar et al 21 examined catheterisation in patients
withandwithoutpassage through theaorticvalve inpatientswithvalvularaortic
stenosis. Crossing the aortic stenosed valve is associated with a potential risk of
dislodgement of calcific valve particles and caused in 22% focal diffusionimaging
abnormalitiesversusnonepercentabnormalitiesinthepatientswithoutpassageof
theaorticvalve.ClarketalfoundthatthepatientswhounderwentCABGandhad
postoperative complications had a higher percentage of emboli occurring while
either the heart or the aortic arch where surgically manipulated 22. Kotoh and
GuerrieriWolf23,24demonstratedthatpartialsideclamping,i.e.manipulationofthe
aortic arch during off pump CABG, is an independent risk factor for cerebral
infarction.
 Abovementionedstudiessupportthehypothesisthatparticulateemboliresult
in more cerebral damage as compared to gaseous emboli. Nevertheless, also
gaseous emboli may be clinically relevant. The underlying pathophysiological
mechanisms were described by Muth et el and Barak et al 15, 16. The vessel wall
shows an inflammatory response due to stress and strain caused by contact of a
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gaseous bubble. Complement activation commences at the airliquid interface.
Micro bubbles induce clotting through both activating coagulation and inducing
platelet aggregation. The bubble acts as a foreign substance and activates the
coagulationcascade.Cerebralgasembolisminitiallyinducestherapiddevelopment
ofcytoxicbrainoedema,diminishingextracellularspaceandenlargingintracellular
areas. Pugsley et al 25 demonstrated that reducing the number of cerebral MES
duringCABGusinganarterial line filter,contributestoareduction inneurological
deficit from 27% to 9%. Emboli eliminated by an arterial filter are most likely
gaseous, suggesting that gaseous emboli are able to cause neurological deficit.
Largeamountsofgaseousembolimayevenbe fatal 15.However,assuggestedby
Stroobant et al, more studies are needed to correlate gaseous MES with
neurologicalimpairmentasforexamplecognitivedecline26.
 The capability to discriminate between gaseous and particulate emboli would
enable a more accurate estimation of the cerebral embolic burden during cardiac
interventions and might result in a better correlation with neurological
complications postprocedurally. The discrimination between particulate and
gaseous emboli could contribute the debate on “on pump versus offpump
surgery”.There isacontroversywhethereitheroftheapproaches is favourable in
termsofneurologicaloutcome 2630. In spiteofa lowernumberofMESduringoff
pumpCABG,acorrelationwiththenumberofMESandneurologicaloutcomecould
notbeestablished.
 In this debate however, no accurate estimation of the embolic load was
achieved, because the composition of the cerebral microemboli was unknown.
Discrimination between particulate and gaseous emboli would allow for a more
realisticcomparisonbetweendifferentproceduresordifferentequipmentinterms




evaluation of RF signals might have the potential to accomplish a more realistic
estimationoftheembolicloadalsowhentheemboliappearinclusters.Automatic
onlinecountingofembolibasedon theaforementioned techniques is likely tobe
only matter of time due to the everincreasing capacity of personal computer




results of the emboli detection will improve the neurological outcome of the
patient. A reliably working automatic emboli detection system would be a
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prerequisiteforconductingsuchstudies.Theresultspresentedinthisthesisaddto
our knowledge on the cerebral emboli during a variety of procedures, which is
necessarytodevelopsuchanautomaticsystem.Onepossibilitytodosomakinguse
oftheRFsignalhasbeenproposed.
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The number of periprocedural cerebral microemboli in cardiac interventions is
associatedwiththeriskofpostproceduralneurologicalcomplications.Transcranial
Doppler(TCD)isanoninvasiveultrasoundmonitoringmethodwhichvisualizesthe
cerebral blood flow by means of a velocity spectrum. Presence of microemboli in
the monitored cerebral vessels can be detected in the velocity spectrum as
microembolicsignals(MES)andanestimationofthetotalcerebralembolicloadfor
a patient undergoing a cardiac procedure can be provided. Reducing the cerebral




 The occurrence of microemboli during perfusionist interventions, e.g. drug
administration,orbloodwithdrawal,hasbeenshowntobeanimportantsourceof
cerebralmicroemboli.Inchapter2anewmethodofwithdrawingbloodsamplesby





line.Thegenerationofmicroemboli in theCPBcouldbe limitedbyusinganextra
shuntlineforreturningbloodintothecirculation.

Not only during cardiac surgery, also after other cardiac interventions may
neurological complications occur due to cerebral microemboli. Pulmonary veins
isolation (PVI) is a therapy for atrial fibrillation. In this procedure, tissue with
abnormalelectricalactivityisdestroyed,whichterminatesatrialfibrillation.In0.5%
to 10% of patients undergoing a PVI procedure, postoperative neurological
complicationsaredocumented.
 In chapter 3 the occurrence of cerebral MES during a catheterbased
percutaneousendocardialPVIprocedureandarecentlydevelopedminimalinvasive
videoassisted thoracoscopic epicardial PVI procedure on a beating heart, is
examined.Thenumberof cerebralMESsignalsdetectedduring theepicardialPVI











regarding the generation of cerebral microemboli: (1) ostial isolation using of a
conventional RF ablation catheter, (2) ostial isolation using of an irrigated RF tip
ablation catheter, and (3) circular isolation of the ostia using a cryocoagulation
catheter. The cryocoagulation catheter and the RF irrigated catheter generated









be impossible, however. A new device, which has the potential to prevent
microemboli in the blood circulation to end up in the cerebral vessels, has been
examined preclinically in chapter 5. This ultrasonic device (EmBlocker™) is
positioned on the distal part of the ascending aorta; by activating the device,




Inchapter6 thisultrasonic technologyhasbeenexamined inpatientsundergoing
cardiacsurgery.TheEmblocker™wasactivatedduringselectedmanipulationsthat
are prone for embolization. This reduced the amount of cerebral MES by
approximately 50%. Thus, the use of the EmBlocker™ in cardiac surgery reduces
perioperative cerebral MES and bears the potential to lower the risk for
postoperativeneurologicalcomplications.

The number of cerebral microemboli occurring cardiac interventions varies from
patient to patient as has been demonstrated in the previous chapters. During
varioustimepointsoruponmanipulationsduringcardiacinterventions,thenumber
of generated microemboli can be very high (e.g., “embolic showers”). Current
methods to count the number of emboli only provide a rough estimation during
embolic showers. The time interval between consecutive emboli must be large
enoughforaccuratedetection.Inembolicshowers,emboliareclusteredtogether,
resulting in an underestimation of embolic load. Inchapter7 an algorithm with a
hightemporalresolution,basedontheradiofrequency(RF)signalofaTCDsystem,
has been designed to improving detection of emboli in embolic showers. The
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algorithm was validated on various recordings made during cardiac surgery and
provided a RFamplitude plot with quantitative information about large emboli















Het aantal cerebrale microembolieën tijdens een hartchirurgische procedure is
geassocieerd met het risico op neurologische complicaties na de procedure.
Transcraniale Doppler (TCD) is een nietinvasieve, op ultrageluid gebaseerde
methode,diedebloedstromingdoordehersenenkanvisualiserenmetbehulpvan
een snelheidsspectrum. De aanwezigheid van microembolieën in de bestudeerde
hersenvaten kan worden gedetecteerd in het snelheidsspectrum als micro
embolische signalen (MES) en daarmee kan een schatting van de totale “embolic
load” in de hersenen worden gemaakt voor een patiënt die een hartchirurgische
procedure ondergaat. Het verlagen van de embolic load in de hersenen zou het




een bloedmonster, zijn een belangrijke oorzaak van het ontstaan van micro
embolieën. In hoofdstuk 2 is een nieuwe methode van het nemen van bloed










Niet alleen bij hartchirurgische, ook na cardiologische ingrepen kunnen er
neurologische complicaties ontstaan door cerebrale microembolieën. Long venen
isolatie (PVI) iseentherapievooratriumfibrilleren.Tijdensdezeprocedurewordt
weefsel met abnormale elektrische activatie vernietigd, waardoor het atrium
fibrillerenwordtbeëindigd.In0.5%tot10%vandepatiëntendieeenPVIprocedure
ondergaan,wordenerpostoperatiefneurologischecomplicatiesgevonden.
 In hoofdstuk 3 is de hoeveelheid cerebrale MES bestudeerd tijdens een
cardiologische endocardiale PVI procedure en tijdens een recent ontwikkelde
minimaal invasieve chirurgische thoracoscopische epicardiale PVI procedure met
eenkloppendhart.HetaantalcerebraleMEStijdensdeepicardialePVImethodeis











verschillende katheters. In hoofdstuk 4 zijn drie cardiologische endocardiale PVI
methodenmetelkaarvergelekenmetbetrekkingtotdeontwikkelingvancerebrale
microembolieën: (1) ostium isolatie met gebruik van een conventionele
radiofrequente (RF) ablatie katheter, (2) ostium isolatie met gebruik van een
gekoelde tip RF katheter, (3) cirkelvormige ostium isolatie met gebruik van een
cryocoagulatiekatheter.DecryocoagulatiekatheterendegekoeldetipRFkatheter
genereren significant minder cerebrale microembolieën dan de conventionele RF
katheter.Hierdoorbestaatdekansdathetrisicoopneurologischecomplicatiesna
een PVI procedure lager is bij gebruik van een cryocoagulatie katheter of een
gekoeldeRFkatheterdanbijgebruikeenconventioneleRFkatheter.

Cerebrale MES kunnen worden verminderd tijdens hartchirurgische en
cardiologische procedures door veranderingen aan de standaard methode
(hoofdstuk 2), door een andere methode voor dezelfde therapie te verkiezen
(hoofdstuk3)endooranderinstrumentariumtegebruiken(hoofdstuk4).
 Desondanks kunnen niet alle cerebrale microembolieën tijdens






richting de “aorta descendens” om zo te voorkomen dat ze in de hersenvaten
terechtkomen. In de preklinische dierstudie is aangetoond dat zowel vaste als





geactiveerd tijdens geselecteerde momenten waarvan bekend is dat er micro
embolieënkunnenontstaan.DezeactivatiesreduceerdenhetaantalcerebraleMES
met ongeveer 50%. Dit resultaat laat zien dat het gebruik van de EmBlocker™
tijdenshartchirurgischeprocedure,hetaantalcerebraleMESkanverminderen,en




Het aantal cerebrale microembolieën dat veroorzaakt wordt tijdens een
hartchirurgischeencardiologischeprocedures,blijktafhankelijkvandefasevande
behandeling en afhankelijk van procedures en gebruikt instrumentarium, zoals is
aangetoond in de genoemde hoofdstukken. Bij verschillende momenten of
manipulaties tijdens hart procedures kan de hoeveelheid gegenereerde micro
embolieën erg hoog worden en kunnen de zogenaamde “embolic
showers” ontstaan.De huidigemethodenomdemicroembolieëntetellenkunnen
alleeneenschattinggevenvanhetaantalMESin“embolicshowers”.Alleenalsde
microembolieën met een bepaalde tijdsperiode na elkaar verschijnen, kunnen ze
accuraat geteld worden. In “embolic showers” verschijnen ze sneller dan de
benodigde tijdsperiode, waardoor de totale hoeveelheid microembolieën wordt
onderschat. Inhoofdstuk7 iseenalgoritmebeschrevendat isgemaaktommicro
embolieën in “embolic showers” nauwkeuriger te tellen. Dit algoritme heeft een
hoge temporele resolutie en is gebaseerd op het ruwe teruggekaatste RF signaal
van de microemboli. Het algoritme was toegepast op verschillende opnames van
“embolic showers” gedurende hartchirugische operaties, en levert amplitude
figurenopdie,kwantitatieve informatiebevatten.Dezeamplitude figuren leveren
eenduidelijkervisueelbeeldvandemicroembolieënineen“embolicshower”,dan
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